HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Giannetti Selected Research

Pruritus (Itching)

3/2000One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Giannetti Research Topics

Disease

7Atopic Dermatitis (Atopic Eczema)
07/2008 - 01/2000
4Psoriasis (Pustulosis Palmaris et Plantaris)
10/2010 - 05/2001
2Hypertension (High Blood Pressure)
01/2013 - 07/2007
2Acute Disease
07/2008 - 06/2008
2Impetigo (Impetigo Contagiosa)
01/2000 - 01/2000
1Epidermolysis Bullosa
09/2015
1Eczema
01/2015
1Anaphylaxis (Anaphylactic Shock)
01/2014
1Diabetes Mellitus
01/2013
1Latex Hypersensitivity (Latex Allergy)
01/2013
1Hypersensitivity (Allergy)
01/2013
1Agammaglobulinemia (Hypogammaglobulinemia)
07/2011
1Urticaria (Hives)
06/2009
1Abdominal Obesity
07/2007
1Melanoma (Melanoma, Malignant)
03/2007
1Neoplasm Metastasis (Metastasis)
03/2007
1Neoplasms (Cancer)
09/2006
1Infections
09/2006
1Atrophy
12/2004
1Chronic Disease (Chronic Diseases)
12/2004
1Scalp Dermatoses
01/2003
1Allergic Rhinitis
03/2000
1Pruritus (Itching)
03/2000
1Angioedema
03/2000
1Chronic Urticaria
03/2000
1Abscess
01/2000
1Inflammation (Inflammations)
01/2000

Drug/Important Bio-Agent (IBA)

3Tacrolimus (Prograf)FDA LinkGeneric
07/2008 - 12/2004
3Ointments (Pastes)IBA
07/2008 - 12/2004
2Immunoglobulin E (IgE)IBA
01/2014 - 01/2013
2TransferasesIBA
01/2013 - 12/2000
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2013 - 10/2010
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
07/2008 - 06/2008
2Calcineurin InhibitorsIBA
11/2005 - 12/2004
2CytokinesIBA
05/2001 - 01/2000
2Messenger RNA (mRNA)IBA
05/2001 - 12/2000
2ChemokinesIBA
05/2001 - 01/2000
1Proteins (Proteins, Gene)FDA Link
09/2015
1CreatinineIBA
01/2013
1Aspartic Acid (Aspartate)FDA Link
01/2013
1Alanine (L-Alanine)FDA Link
01/2013
1LDL CholesterolIBA
01/2013
1LatexIBA
01/2013
1Rubber (Elastica)IBA
01/2013
1Triglycerides (Triacylglycerol)IBA
01/2013
1Immunoglobulin G (IgG)IBA
07/2011
1HDL CholesterolIBA
07/2007
1CaspasesIBA
03/2007
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
03/2007
1Folic Acid AntagonistsIBA
03/2007
1Thymidylate SynthaseIBA
03/2007
1Biological ProductsIBA
09/2006
1Etanercept (Enbrel)FDA Link
09/2006
1pimecrolimus (Elidel)FDA Link
12/2004
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2004
1EmollientsIBA
12/2004
1Hydrocortisone (Cortisol)FDA LinkGeneric
12/2004
1SteroidsIBA
12/2004
1Betamethasone Valerate (Betamethasone 17 Valerate)FDA LinkGeneric
01/2003
1Interleukin-8 (Interleukin 8)IBA
05/2001
1Chemokine CCL5IBA
05/2001
1Tetradecanoylphorbol AcetateIBA
12/2000
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
12/2000
1NF-kappa B (NF-kB)IBA
12/2000
1Chloramphenicol (Chloromycetin)FDA Link
12/2000
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
12/2000
1A-factor (Streptomyces)IBA
12/2000
1mizolastine (Zolim)IBA
03/2000
1Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA
03/2000
1DNA (Deoxyribonucleic Acid)IBA
01/2000

Therapy/Procedure

5Therapeutics
01/2015 - 03/2000
1Complementary Therapies (Alternative Medicine)
06/2009
1Aftercare (After-Treatment)
03/2007
1Drug Therapy (Chemotherapy)
03/2007
1Radiotherapy
03/2007
1Contraindications
09/2006
1Biological Therapy
09/2006
1Central Venous Catheters
01/2000